Trifluperidol



Trifluperidol
Systematic (IUPAC) name
1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-piperidyl]butan-1-one
Identifiers
CAS number 749-13-3
ATC code N05AD02
PubChem 5567
Chemical data
O2 
Mol. mass 409.417 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Trifluperidol is a extrapyramidal effects. It is used in the treatment of psychoses including mania and schizophrenia.

Trifluperidol was discovered at Janssen Pharmaceutica in 1959.

References

  • Gallant DM, Bishop MP, Timmons E, Steele CA, A controlled evaluation of Trifluperidol: a new potent psychopharmacologic agent, Curr Ther Res Clin Exp. 1963 Sep;27:463-71.
  • Gallant DM, Bishop MP, Timmons E, Steele CA, Trifluperidol: a butyrophenone derivative, Am J Psychiatry. 1963 Nov;120:485-7.



v • d • e
Psycholeptics: antipsychotics (Zotepine)
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Trifluperidol". A list of authors is available in Wikipedia.